Avondale Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Avondale Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-44	Closed	-$23.4K	–	126
2023 Q4	$23.4K	Hold	44	–	–	0.02%	101
2023 Q3	$22.3K	Hold	44	–	–	0.02%	103
2023 Q2	$23K	Hold	44	–	–	0.02%	100
2023 Q1	$25.4K	Hold	44	–	–	0.02%	101
2022 Q4	$24.2K	Hold	44	–	–	0.02%	92
2022 Q3	$22K	Hold	44	–	–	0.02%	93
2022 Q2	$24K	Sell	44 -46	-51%	-$25.3K	0.03%	84
2022 Q1	$53K	Hold	90	–	–	0.06%	64
2021 Q4	$60K	Sell	90 -27	-23%	-$16.9K	0.06%	62
2021 Q3	$67K	Hold	117	–	–	0.07%	65
2021 Q2	$59K	Hold	117	–	–	0.06%	68
2021 Q1	$53K	Hold	117	–	–	0.05%	66
2020 Q4	$54K	Hold	117	–	–	0.06%	52
2020 Q3	$52K	Hold	117	–	–	0.08%	38
2020 Q2	$42K	Hold	117	–	–	0.06%	44
2020 Q1	$33K	Hold	117	–	–	0.05%	51
2019 Q4	$38K	Hold	117	–	–	0.06%	52
2019 Q3	$34K	Hold	117	–	–	0.06%	54
2019 Q2	$34K	Hold	117	–	–	0.03%	58
2019 Q1	$32K	Hold	117	–	–	0.02%	60
2018 Q4	$26K	Hold	117	–	–	0.02%	67
2018 Q3	$29K	Hold	117	–	–	0.03%	57
2018 Q2	$24K	Hold	117	–	–	0.02%	58
2018 Q1	$24K	Hold	117	–	–	0.02%	59
2017 Q4	$22K	Buy	+117	New	+$22.4K	0.02%	67

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Avondale Wealth Management's TMO Position: Q1 2024 in Review

Avondale Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 44 shares — an estimated $23.4K sold.

Avondale Wealth Management first reported a position in TMO in Q4 2017 and held it in 25 quarters. The position peaked at $67K in Q3 2021. 2,534 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

Avondale Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
Avondale Wealth Management sold 44 Thermo Fisher Scientific shares in Q1 2024, an estimated $23.4K.
Avondale Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 25 quarters.
Avondale Wealth Management's Thermo Fisher Scientific position peaked at $67K in Q3 2021.
2,534 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Avondale Wealth Management's 13F filing for Q1 2024, filed 2 Apr 2024.